211 related articles for article (PubMed ID: 33230147)
1. Osteoclast-expanded super-charged NK-cells preferentially select and expand CD8+ T cells.
Kaur K; Ko MW; Ohanian N; Cook J; Jewett A
Sci Rep; 2020 Nov; 10(1):20363. PubMed ID: 33230147
[TBL] [Abstract][Full Text] [Related]
2. Novel Strategy to Expand Super-Charged NK Cells with Significant Potential to Lyse and Differentiate Cancer Stem Cells: Differences in NK Expansion and Function between Healthy and Cancer Patients.
Kaur K; Cook J; Park SH; Topchyan P; Kozlowska A; Ohanian N; Fang C; Nishimura I; Jewett A
Front Immunol; 2017; 8():297. PubMed ID: 28424683
[TBL] [Abstract][Full Text] [Related]
3. Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens.
Tosi D; Valenti R; Cova A; Sovena G; Huber V; Pilla L; Arienti F; Belardelli F; Parmiani G; Rivoltini L
J Immunol; 2004 May; 172(9):5363-70. PubMed ID: 15100276
[TBL] [Abstract][Full Text] [Related]
4. Osteoclasts and Probiotics Mediate Significant Expansion, Functional Activation and Supercharging in NK, γδ T, and CD3+ T Cells: Use in Cancer Immunotherapy.
Kaur K; Jewett A
Cells; 2024 Jan; 13(3):. PubMed ID: 38334605
[TBL] [Abstract][Full Text] [Related]
5. Modification of anti-tumor immunity by tolerogenic dendritic cells.
Chen L; Hasni MS; Jondal M; Yakimchuk K
Autoimmunity; 2017 Sep; 50(6):370-376. PubMed ID: 28675711
[TBL] [Abstract][Full Text] [Related]
6. Gene transfer of the CD40-ligand to human dendritic cells induces NK-mediated antitumor effects against human carcinoma cells.
Tomihara K; Kato K; Masuta Y; Nakamura K; Tanaka T; Hiratsuka H; Hamada H
Int J Cancer; 2007 Apr; 120(7):1491-8. PubMed ID: 17205529
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotyping of patients with oral squamous cell carcinoma in peripheral blood and associated tumor tissue.
Grimm M; Feyen O; Hofmann H; Teriete P; Biegner T; Munz A; Reinert S
Tumour Biol; 2016 Mar; 37(3):3807-16. PubMed ID: 26474587
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cells prime the responsiveness of autologous CD4+ T cells to CTLA4-Ig and interleukin-10 mediated inhibition in an allogeneic dendritic cell-mixed lymphocyte reaction.
Newland A; Russ G; Krishnan R
Immunology; 2006 Jun; 118(2):216-23. PubMed ID: 16771856
[TBL] [Abstract][Full Text] [Related]
9. Induction of human papillomavirus-specific CD4(+) and CD8(+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer.
Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Zhan D; Pecorelli S; Parham GP; Cannon MJ
J Virol; 1999 Jul; 73(7):5402-10. PubMed ID: 10364287
[TBL] [Abstract][Full Text] [Related]
10. Contribution of NK, NK T, gamma delta T, and alpha beta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi.
Sardinha LR; Elias RM; Mosca T; Bastos KR; Marinho CR; D'Império Lima MR; Alvarez JM
Infect Immun; 2006 Apr; 74(4):2031-42. PubMed ID: 16552032
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function.
Mailliard RB; Son YI; Redlinger R; Coates PT; Giermasz A; Morel PA; Storkus WJ; Kalinski P
J Immunol; 2003 Sep; 171(5):2366-73. PubMed ID: 12928383
[TBL] [Abstract][Full Text] [Related]
12. Altered invariant natural killer T cell subsets and its functions in patients with oral squamous cell carcinoma.
Singh AK; Shukla NK; Das SN
Scand J Immunol; 2013 Nov; 78(5):468-77. PubMed ID: 23980793
[TBL] [Abstract][Full Text] [Related]
13. CD8(+) T activation attenuates CD4(+) T proliferation through dendritic cells modification.
Chen D; Wang Y; Wang H; Wu Y; Xia S; Zhang M
Cell Immunol; 2015 Aug; 296(2):138-48. PubMed ID: 26022412
[TBL] [Abstract][Full Text] [Related]
14. NK cells shape pancreatic and oral tumor microenvironments; role in inhibition of tumor growth and metastasis.
Jewett A; Kos J; Fong Y; Ko MW; Safaei T; Perišić Nanut M; Kaur K
Semin Cancer Biol; 2018 Dec; 53():178-188. PubMed ID: 30081230
[TBL] [Abstract][Full Text] [Related]
15. NK cells regulate CD8+ T cell effector function in response to an intracellular pathogen.
Vankayalapati R; Klucar P; Wizel B; Weis SE; Samten B; Safi H; Shams H; Barnes PF
J Immunol; 2004 Jan; 172(1):130-7. PubMed ID: 14688318
[TBL] [Abstract][Full Text] [Related]
16. Engineering hematopoietic grafts: purified allogeneic hematopoietic stem cells plus expanded CD8+ NK-T cells in the treatment of lymphoma.
Verneris MR; Ito M; Baker J; Arshi A; Negrin RS; Shizuru JA
Biol Blood Marrow Transplant; 2001; 7(10):532-42. PubMed ID: 11760085
[TBL] [Abstract][Full Text] [Related]
17. Differential infiltration of CD8+ and NK cells in lip and oral cavity squamous cell carcinoma.
Zancope E; Costa NL; Junqueira-Kipnis AP; Valadares MC; Silva TA; Leles CR; Mendonça EF; Batista AC
J Oral Pathol Med; 2010 Feb; 39(2):162-7. PubMed ID: 19754647
[TBL] [Abstract][Full Text] [Related]
18. NK cells and conventional dendritic cells engage in reciprocal activation for the induction of inflammatory responses during Plasmodium berghei ANKA infection.
Ryg-Cornejo V; Nie CQ; Bernard NJ; Lundie RJ; Evans KJ; Crabb BS; Schofield L; Hansen DS
Immunobiology; 2013 Feb; 218(2):263-71. PubMed ID: 22704523
[TBL] [Abstract][Full Text] [Related]
19. NK cells are required for dendritic cell-based immunotherapy at the time of tumor challenge.
Bouwer AL; Saunderson SC; Caldwell FJ; Damani TT; Pelham SJ; Dunn AC; Jack RW; Stoitzner P; McLellan AD
J Immunol; 2014 Mar; 192(5):2514-21. PubMed ID: 24477907
[TBL] [Abstract][Full Text] [Related]
20. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]